|
~
Research Funding Opportunity Announcement from NIH ~
Mechanisms, Models, Measurement, and Management in Pain
Research (R01)
(PA-07-282)
http://grants.nih.gov/grants/guide/pa-files/PA-07-282.html
There is some good news for
fibromyalgia and other chronic pain conditions coming
from the National Institutes of Health (NIH)! The NIH
announced today, a Funding Opportunity Announcement (FOA),
requesting applications from researchers who have a
special interest in acute and chronic pain conditions.
In this announcement, it was noted that pain is the most
common reason for medical appointments and the
associated lost productivity is costing billions of
dollars each year. In 1996 the NIH established an
initiative called “Advances in Pain Research”, for
researchers throughout the NIH to collaborate on
programs addressing pain. Congress declared 2001-2010 to
be a Decade of Pain Control and Research. In addition,
there was language in a bill passed several years ago,
requesting a collaborated effort between NIH institutes
to research fibromyalgia. In the most recent Pain
Consortium symposium in April, 2006”, the NIH again
stressed the need for more research on pain control and
prevention.
Although some progress has been made in these efforts,
the understanding of pain and the handling of pain
control has been found to be inadequate. There have been
many advances in research, with the recent findings
involving brain imaging of pain being very exciting.
Other research discoveries involving neurotransmitters
and pain processing are promising, but incomplete.
This project crosses many of the NIH institutes,
including (but not limited to) two important ones for
fibromyalgia:
- National Institute of
Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
(http://www.niams.nih.gov)
which is the traditional home of fibromyalgia
research;
- National Institute of
Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov).
In this proposed funding
opportunity, a small sampling of the conditions
recommended to be researched include:
- Back pain and other
musculoskeletal pain
- Fibromyalgia
- Headache
- Neuropathic pain
- Temporomandibular joint and
muscle disorders
From the Program Overview, I
would like to highlight the following paragraphs:
“The purpose of this Funding
Opportunity Announcement (FOA), “Mechanisms, Models,
Measurement, & Management in Pain Research,” is to
inform the scientific community of the pain research
interests of the various Institutes and Centers
(ICs) at the National Institutes of Health (NIH) and
to stimulate and foster a wide range of basic,
clinical, and translational studies on pain as they
relate to the missions of these ICs.”
And:
“New and innovative advances
are needed in every area of pain research, from the
micro perspective of molecular sciences to the macro
perspective of behavioral/social sciences. Although
great strides have been made in some areas, such as
the neural pathways of pain, pain and the challenge
of its treatment have remained uniquely individual
and largely unsolved. Proposals that seek to improve
the understanding of the causes, costs, and societal
effects of both acute and chronic pain and the
relationships between the two are highly encouraged.
Additionally, proposals that link such
understandings to the development of better
approaches to therapeutic interventions, including
complementary and alternative medicine (CAM)
interventions, and management of acute and chronic
pain are in keeping with the current translational
focus of NIH and are encouraged.”
Below I have provided the text
about the program, with details about the program
objectives. To see the complete Funding Opportunity
Announcement (FOA) in its entirety, use this link:
http://grants.nih.gov/grants/guide/pa-files/PA-07-282.html
Thank you to the NIH!
cc:
Dr. Elias Zerhouni (NIH)
Dr. Stephen Katz (NAIMS)
Dr. Audrey Penn (NINDS)
Sincerely,
Shari Ferbert
President AFFTER
Advocates for Fibromyalgia Funding,
Treatment, Education and Research
www.affter.org |
Why Donate To AFFTER?
AFFTER continues to
grow and prosper as a not-for-profit organization, just as awareness of
fibromyalgia has spread throughout the general population. Recent TV commercials
about fibromyalgia have caused people to seek a diagnosis for their myriad of
symptoms; they are seeking information and support. AFFTER is proud to be the
one that so many turn to. Our presence and credibility within the medical and
fibromyalgia communities are undisputed as we celebrate our 12th year as a
501(c)3 not-for-profit organization.
AFFTER is on a mission to help those affected by fibromyalgia. We continue to
advocate and create awareness for fibromyalgia; provide educational materials
for the patient population, medical community and the general public; and
coordinate charitable events to fund fibromyalgia research, including some of
our own.
Results of our research were the subject of abstract presentations at the annual
conference of the American College of Rheumatology (ACR) in 2008, 2009 and 2010.
Our 5k Charitable Event in 2009 was fruitful, as was the “Hope Rocks” pageant in
2010. AFFTER keeps momentum going into 2011 with two events; “Miss Hope”
charitable pageant in May to celebrate Fibromyalgia Awareness Day, and AFFTER’s
“Hope Relay for Fibromyalgia” in August. Proceeds from these events go directly
into an account designated specifically tor research.
Donations entrusted to AFFTER are used wisely and are necessary for us to
operate. AFFTER is passionate about our cause. We offer ongoing support and
education to keep you informed of research news, updates from the medical
community and educational materials from a variety of sources. Our on-line news
groups have been helping to connect and support people from around the globe for
almost a decade.
Facebook has enabled us to reach out to even more people in recent months.
Please join AFFTER in our quest to make a difference in the lives of those with
fibromyalgia!
Click
here to print out a Donation Form or use the PayPal Button to the left.
* You do not need a
PayPal account to Donate to AFFTER, All donations are 100% tax deductible.
|